jasmine x4

To better ensure the safety of your goods, professional, environmentally friendly, convenient and efficient packaging services will be provided.

ZIBO XINHUA CHAIN PHARMACY is a wholly-owned subsidiary of Shandong Xinhua Pharmaceutical Co., Ltd. As the largest antipyretic and analgesic drug production base in the world, the parent company Xinhua Pharmaceutical has many years of experience in international cooperation. Xinhua Pharmaceutical's internationalization process since 1992, has established close strategic partnerships with Bayer, Johnson & Johnson, GlaxoSmithKline Pfizer and other international pharmaceutical giants. The Xinhua CHAIN Pharmacy is one of a company that started its e-commerce business earlier in China. In 2014, we obtained the C certificate for Internet drug trading, and passed the new GSP certification in Zibo City. Participated in the country's first government-led "prescription off-campus circulation" project targeting the city's public hospitals.
After 76 years of development, Xinhua Pharmaceutical has become an important center for the development and manufacture of antipyretic and analgesic drugs in the world. It is also an important manufacturer of cardiovascular and cerebrovascular, anti-infective, central nervous and digestive drugs in China. It is a listed company and a national high-tech enterprise listed in Hong Kong and Shenzhen. It has a state-level enterprise technology center, an academician workstation, and a postdoctoral workstation.
Xinhua Pharmaceutical always adheres to the concept of green supremacy and ecological development, builds environmentally friendly enterprises and develops a circular economy. Vigorously promote intelligent manufacturing, a batch of intelligent production lines, data acquisition and monitoring systems, intelligent control systems, intelligent logistics and warehousing systems, and a unified platform for life-cycle data, which have been put into operation one after another. The construction of smart enterprises is strongly changing the development model of enterprises.The Xinhua E-commerce Innovation Park will be built, and multi-dimensional strategic cooperation with industry giants such as Jingdong, Ali, and Amazon will be established, and an innovative development path will be developed in the field of big health. Adhering to the concept of two lives, Xinhua Pharmaceutical has established a whole process and full-quality quality assurance system. All products have passed GMP certification, and the main products have passed the certifications of  EU EDQM.
Focused on pharmaceuticals for 76 years, forming a distinctive product structure. Based on large-scale and serialized development of APIs, the company has developed seven major API products, among which, the annual production capacity of ibuprofen series, aspirin series and Dopa series ranks first in the world.We will implement the strategy of large pharmaceutical preparations, develop high-end pharmaceutical preparations and brand-name drugs, and put innovative drugs on the market in batches. Xinhua brand-name preparations are getting more and more recognized by the majority of patients.
Innovation is the most persistent endowment of Xinhua Pharmaceutical.Today, Xinhua has formed a stronger team of professionals. Xinhua Pharmaceutical has established six centers of Pharmaceutical Chemistry Research Center, Drug Quality Research Center, Pharmaceutical Preparation Research Center, Biotechnology Center, Innovative Drug Joint Research Beijing Center and Scientific Research Management Center. The research include antipyretic and analgesic, cardiovascular and cerebrovascular, anti-tumor, anti-infective, anti-metabolic, digestive, biopharmaceutical and health care products. In 2018, the international pharmaceutical cooperation center with a capacity of 20 billion pieces was completed and put into production. With the high-end preparation products such as Bayer, Pfizer, Roche, DSM, and Perrigo, many high-end preparation products have settled.

1. who are we?
We are based in Shandong, China, start from 1999,sell to Domestic Market(85.00%),South Asia(10.00%),North America(5.00%). There are total about 1000+ people in our office.

2. how can we guarantee quality?
Always a pre-production sample before mass production;
Always final Inspection before shipment;

3.what can you buy from us?
Ibuprofen Tablets,Melatonin Tablets,Vitamins Tablets,Contact Lenses,API,Preparations,Pharmaceutical Intermediates

4. why should you buy from us not from other suppliers?
ZIBO XINHUA CHAIN PHARMACY COMPANY, is a wholly-owned subsidiary of Shandong Xinhua Pharmaceutical Co., Ltd which is the world's largest antipyretic and analgesic drug production base & established close partnerships with Bayer, Johnson & Johnson, Pfizer.

5. what services can we provide?
Accepted Delivery Terms: FOB；
Accepted Payment Currency:USD,CNY;
Accepted Payment Type: T/T;
Language Spoken:English,Chinese,Japanese